✦ LIBER ✦

Follow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: results after 5 years

✍ Scribed by Pi-Chuan Fan; Mei-Hwei Chang; Ping-Ing Lee; A. Safary; Chin-Yun Lee

Book ID: 117432678
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 512 KB
Volume: 16
Category: Article
ISSN: 0264-410X
DOI: 10.1016/s0264-410x(97)00179-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity of an inactivated hepatit

Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up

✍ Ron Dagan; David Greenberg; Françoise Weber 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Safety and immunogenicity of an inactiva

Safety and immunogenicity of an inactivated hepatitis A vaccine in children 2 to 5 years old

✍ J. Arístegui; E. Garrote; J. L. Morales; Maria S. Gallego; R. Dal-Ré; A. Gonzále 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 861 KB

Long-term immunogenicity after single an

Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: Results from 8-year follow-up

✍ Xuan-Yi Wang; Zhi-Yi Xu; Jing-Chen Ma; Lorenz von Seidlein; Yong Zhang; Zhi-Yong 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Safety, immunogenicity and antibody pers

Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children

✍ Olga Castillo de Febres; Maria Chacon de Petrola; Laddy Casanova de Escalona; Os 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Safety and immunogenicity of an inactiva

Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: A prospective, open-label, multi-center trial

✍ Chi-Eun Oh; Jina Lee; Jin-Han Kang; Young-Jin Hong; Yun-Kyung Kim; Hee-Jin Cheon 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 230 KB

Five-year follow-up of a prospective ran

Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: Immunogenicity and anamnestic responses

✍ Dr. Ching-Lung Lai; Benjamin Chun-Yu Wong; Eng-Kiong Yeoh; Wai-Ling Lim; Wai-Kwa 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 517 KB

In a prospective randomized trial, 318 children aged between 3 mo and 11 yr who were negative for all hepatitis B markers were randomized to receive two 5-pg doses of hepatitis B recombinant DNA yeast vaccine at 0 and 1 m o (group 11, three 5 -~g doses of hepatitis B recombinant DNA yeast vaccine at